| 2601 |
Cord Tissue |
Allogeneic – Unrelated |
Encephalopathy |
Neurology |
2022 |
Experimental Therapy |
Poland |
51,4 |
| 2602 |
Cord Tissue |
Allogeneic – Unrelated |
Encephalopathy |
Neurology |
2022 |
Experimental Therapy |
Poland |
8,3 |
| 2603 |
Cord Tissue |
Allogeneic – Unrelated |
Epidermolysis Bullosa |
Dermatology |
2022 |
Experimental Therapy |
Poland |
18,4 |
| 2604 |
Cord Tissue |
Allogeneic – Unrelated |
Epilepsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,5 |
| 2605 |
Cord Tissue |
Allogeneic – Unrelated |
Epilepsy; Global Developmental Delay; Hypoxic Encephalopathy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,6 |
| 2606 |
Cord Tissue |
Allogeneic – Unrelated |
Epileptic Encephalopathy |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,1 |
| 2607 |
Cord Tissue |
Allogeneic – Unrelated |
Global Developmental Delay |
Neurology |
2022 |
Experimental Therapy |
Poland |
10,2 |
| 2608 |
Cord Tissue |
Allogeneic – Unrelated |
Gonarthrosis |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
56,3 |
| 2609 |
Cord Tissue |
Allogeneic – Unrelated |
Gonarthrosis |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
38,7 |
| 2610 |
Cord Tissue |
Allogeneic – Unrelated |
Gonarthrosis |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
49,1 |
| 2611 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2022 |
Experimental Therapy |
Poland |
1,1 |
| 2612 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2022 |
Experimental Therapy |
Poland |
2,11 |
| 2613 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2022 |
Experimental Therapy |
Poland |
16,1 |
| 2614 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,7 |
| 2615 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
11,7 |
| 2616 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
4,2 |
| 2617 |
Cord Tissue |
Allogeneic – Related |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Romania |
3 |
| 2618 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,1 |
| 2619 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,3 |
| 2620 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
4,7 |
| 2621 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,5 |
| 2622 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
47,1 |
| 2623 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
22,11 |
| 2624 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
49,1 |
| 2625 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
54,6 |
| 2626 |
Cord Tissue |
Allogeneic – Unrelated |
Muscular Dystrophy |
Neurology |
2022 |
Experimental Therapy |
Poland |
62,9 |
| 2627 |
Cord Tissue |
Allogeneic – Unrelated |
Myelomeningocele |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,3 |
| 2628 |
Cord Tissue |
Allogeneic – Unrelated |
Myelomeningocele |
Neurology |
2022 |
Experimental Therapy |
Poland |
1,4 |
| 2629 |
Cord Tissue |
Allogeneic – Unrelated |
Optic Atrophy |
Ophthalmology |
2022 |
Experimental Therapy |
Poland |
25,7 |
| 2630 |
Cord Tissue |
Allogeneic – Unrelated |
Optic Atrophy |
Ophthalmology |
2022 |
Experimental Therapy |
Poland |
14,1 |
| 2631 |
Cord Tissue |
Allogeneic – Unrelated |
Optic Atrophy |
Ophthalmology |
2022 |
Experimental Therapy |
Poland |
26,1 |
| 2632 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2022 |
Experimental Therapy |
Poland |
37,11 |
| 2633 |
Cord Tissue |
Allogeneic – Unrelated |
Premature Ovarian Failure; Status After Oncological Treatment Of Breast Cancer |
Gynecology |
2022 |
Experimental Therapy |
Poland |
45,2 |
| 2634 |
Cord Tissue |
Allogeneic – Unrelated |
Sclerosis Multiplex |
Neurology |
2022 |
Experimental Therapy |
Poland |
41,3 |
| 2635 |
Cord Tissue |
Allogeneic – Unrelated |
Sequelae Of Spinal Cord Injury; Condition After A Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
23,9 |
| 2636 |
Cord Tissue |
Allogeneic – Unrelated |
Spasmic Paralysis Of The Limbs |
Neurology |
2022 |
Experimental Therapy |
Poland |
33,9 |
| 2637 |
Cord Tissue |
Allogeneic – Unrelated |
Spastic Limb Paralysis |
Neurology |
2022 |
Experimental Therapy |
Poland |
30,11 |
| 2638 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
12,11 |
| 2639 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
20 |
| 2640 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
39,11 |
| 2641 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2022 |
Experimental Therapy |
Poland |
35,6 |
| 2642 |
Cord Blood |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
46 |
| 2643 |
Cord Blood |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2644 |
Cord Blood |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
2,5 |
| 2645 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7 |
| 2646 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Hungary |
13 |
| 2647 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
8,8 |
| 2648 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Romania |
5 |
| 2649 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
UK |
11 |
| 2650 |
Cord Blood |
Allogeneic – Related |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Turkey |
19 |
| 2651 |
Cord Blood |
Autologous |
Hydrocephalus |
Neurology |
2022 |
Experimental Therapy |
Romania |
6 |
| 2652 |
Cord Blood |
Allogeneic – Related |
Sickle Cell Anemia |
Hematology |
2022 |
Standard Therapy |
Turkey |
7,7 |
| 2653 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2022 |
Standard Therapy |
Turkey |
19,2 |
| 2654 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2655 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2656 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2657 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2658 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2659 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
79 |
| 2660 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
23 |
| 2661 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2662 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2663 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 2664 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2665 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2666 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2667 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
43 |
| 2668 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2669 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2670 |
Bone Marrow Family |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2671 |
Bone Marrow Family |
Allogeneic |
Blastic Plasmacytoid Dendritic Cell Neoplasm |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2672 |
Bone Marrow Family |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2673 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2674 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia, Type 2 |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2675 |
Bone Marrow Family |
Allogeneic |
Leukocyte Adhesion Deficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
33 |
| 2676 |
Bone Marrow Family |
Allogeneic |
Mycosis Fungoides |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2677 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 2678 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 2679 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2680 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 2681 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 2682 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2683 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2684 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis Post Essential Thrombocythemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2685 |
Bone Marrow Family |
Allogeneic |
Myeloma Multiplex |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2686 |
Bone Marrow Family |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
73 |
| 2687 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2688 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2689 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2690 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2691 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2692 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2693 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2694 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2695 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
38 |
| 2696 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2697 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2698 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2699 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2700 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |